Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
about
Measures to Control Phlebotomus argentipes and Visceral Leishmaniasis in IndiaCombined Immune Therapy for the Treatment of Visceral LeishmaniasisImmune regulation during chronic visceral leishmaniasis.IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic testHeterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature ReviewLongitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.Characterisation of cutaneous leishmaniasis in Matara district, southern Sri Lanka: evidence for case clustering.Awareness of visceral leishmaniasis and its relationship to canine infection in riverside endemic areas in Northeastern Brazil.Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India.Neglected Tropical Diseases: Epidemiology and Global Burden
P2860
Q26745702-B7B4ED11-2B46-4204-949F-5E6FE0961518Q28550162-8963A0D4-F346-4ADF-B9FA-2E50065A6405Q33881718-4A2524CA-98E8-4F27-AD1C-B2C0643A2465Q34395015-4D65F396-BBDD-4A51-914B-A56B0F634DA3Q35143788-6C017980-8715-4E77-9310-EC5B49B02B50Q36019612-6085F00F-C39A-4399-9141-6BF93279A8CEQ36094815-4761D3AE-7D9A-455E-8727-FE9BB5C63E49Q36224222-C53A8BD6-DEDB-4698-88EE-DD2A985BD403Q36508569-8ECDF548-028C-44E3-A7C5-F16168621C27Q36622819-2F194DEA-A298-40D5-9272-CE4E820736EFQ41622983-CCA54506-C68C-4F38-8EE7-B22AAC38361CQ47143395-16AECD07-FC4D-48FD-8D01-972DACA1DE41Q57152668-3805DB7A-2571-4C59-B089-4248D5838547
P2860
Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk factors for visceral leis ...... infection in India and Nepal.
@en
Risk factors for visceral leis ...... infection in India and Nepal.
@nl
type
label
Risk factors for visceral leis ...... infection in India and Nepal.
@en
Risk factors for visceral leis ...... infection in India and Nepal.
@nl
prefLabel
Risk factors for visceral leis ...... infection in India and Nepal.
@en
Risk factors for visceral leis ...... infection in India and Nepal.
@nl
P2093
P2860
P50
P921
P1433
P1476
Risk factors for visceral leis ...... infection in India and Nepal.
@en
P2093
Bart Ostyn
Epco Hasker
Shri Prakash Singh
Suman Rijal
Surendra Uranw
P2860
P304
P356
10.1371/JOURNAL.PONE.0087641
P407
P577
2014-01-31T00:00:00Z